期刊文献+

家族性玻璃体淀粉样变性甲状腺激素结合蛋白Gly83Arg突变一家系 被引量:8

原文传递
导出
摘要 家族性玻璃体淀粉样变性(FTA)属常染色体显性遗传性疾病。因淀粉样物质在玻璃体沉积致病。研究最多并与眼部淀粉样变性特别是与玻璃体淀粉样变性密切相关的基因为甲状腺激素结合蛋白(TTR);目前已知和淀粉样变性相关的TTR基因突变有100多种。
出处 《中华眼底病杂志》 CAS CSCD 北大核心 2016年第3期312-314,共3页 Chinese Journal of Ocular Fundus Diseases
基金 贵州省科学技术基金(黔科合计省合[2014]7007号)
  • 相关文献

参考文献15

  • 1Doft BH, Machemer R, Skinner M, et al. Pars plana vitreetomy for vitreous amyloidosis [J]. Ophthalmology, 1987,94 (6) : 607- 611.
  • 2Benson MD. Leptomeningeal amyloid and variant transthyretins [J]. Am J Pathol,1996,148(2) :351-354.
  • 3Tsuzuki T, Mita S, Maeda S, et al. Structure of the human prealbumin gene [J]. J Biol Chem, 1985,260 (22) 12224-12227.
  • 4石一宁,胡笳,李静,胡军,孙丽君,李慧瑾,石蕊,杨乐,孙烨,李婵,张纯涛,陈研明.家族性玻璃体淀粉样变性患者甲状腺激素结合蛋白基因突变研究[J].中华眼底病杂志,2011,27(5):482-484. 被引量:7
  • 5陈凌燕,吕林,张平,李永浩,林健贤.玻璃体淀粉样变性伴转甲蛋白Arg-83突变一例[J].眼科学报,2008,24(1):65-67. 被引量:21
  • 6Shi YN, Hu J, Li J, et al. Study of the transthyretin gene mutation in familial vitreous amyloidosis subjects [J]. Chin J Ocul Fundus Dis, 2011,27(5) :482-484. DOI: 10. 3760/cma. j. issn. 1005-1015. 2011.05. 019.
  • 7Chen LY, Lyu L, Zhang P, et al. Transthyretin Arg-83 mutation in vitreous amyloidosis [J]. Eye Sci, 2008,24 ( 1 ) : 65- 67. DOI: 10. 3969/j. issn. 1000-4432. 2008.01. 016.
  • 8Zou X, Dong F, Zhang S, et al. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor [J]. Exp Eye Res, 2013, 110:44-49.
  • 9Long D, Zeng J, Wu I.Q, et al. Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thrand Leu55Arg[J]. Ophthalmic Genet, 2012, 33(1) :28-33.
  • 10Zhang Y, Deng YL, Ma JF, et al. Transthyretin related hereditary amyloidosis in a chinese family with TTR Yl14C mutation[J]. Neurodegener Dis, 2011, 8(4):187-193.

二级参考文献23

  • 1乔春艳,卢宁,魏文斌.玻璃体淀粉样变性合并青光眼一例[J].眼科,2004,13(4):199-200. 被引量:14
  • 2樊冬生.玻璃体切割术治疗玻璃体淀粉样变性3例[J].眼科新进展,2007,27(5):398-399. 被引量:11
  • 3[4]Monteim JG,Ferreira AP,Figueira AS,et al.Vitreous opacities in familial amyloid polyneuropathy.In:Costa PP,Freitas AS,Saraiva MJM,eds.Familial amyloidotic polyneuropathy and other transthyretin disorders.Porto,Arquivous de Medicina,1990;323-328.
  • 4[5]Zambarakji ILl,Charteris DG,Ayliffe W.Vitreous amyloidosis in alanine 71 transthyretin mutation.Br J Ophthalmol,2005;89(6):773-774.
  • 5[6]Doft BH,Machemer R,Skinner M,et al.Pars Plana Vitrectomy for vitreous amyloidosis.Ophthalmology,1987;94(6):607-611.
  • 6[7]Palon D,Duke JR.Primary familial amyloidosis.Ocular manifestations with histopathologic observations.Am J Ophthalmol,1966;61(4):736-747.
  • 7[8]Connors LH,Richardson AM,Theberge R,et al.Tabulation of transthyretin(TTR) variants as of 1/1/2000.Amyloid,2000;7(1):54-69.
  • 8Benson MD. Ostertag revisited: the inherited systemic amyloidoses without neuropathy. Amyloid,2005,12 : 75-87.
  • 9Benson MD, Kluve-Beckerman B, Zeldenrust SR, et al. Targeted suppression of an amyloidigenic transthyrein with antisense oligonueleotides. Muscle Nerve, 2006,33 : 609-618.
  • 10Saraiva MJ. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum Mutat,2001,17:493-503.

共引文献22

同被引文献30

引证文献8

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部